Top Growth Stocks To Watch Now - July 12th

Circle Internet Group, Blackstone, BlackRock, Blueprint Medicines, and Novo Nordisk A/S are the five Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies projected to increase their revenues and earnings at an above-average rate compared with the overall market, typically by reinvesting profits into research, development or expansion rather than paying dividends. Because investors pay a premium for high growth potential, these stocks often trade at elevated price-to-earnings ratios and can exhibit greater price volatility. Buyers of growth stocks seek substantial capital appreciation over the long term, accepting the risk that actual growth may fall short of expectations. These companies had the highest dollar trading volume of any Growth stocks within the last several days.

Circle Internet Group (CRCL)

Founded in 2013, Circle's mission is to raise global economic prosperity through the frictionless exchange of value. We intend to connect the world more deeply by building a new global economic system on the foundation of the internet, and to facilitate the creation of a world where everyone, everywhere can share value as easily as we can today share information, content, and communications.

Shares of NYSE:CRCL traded down $16.15 during mid-day trading on Friday, reaching $186.75. 18,163,958 shares of the company's stock were exchanged, compared to its average volume of 38,045,640. The firm has a market cap of $41.56 billion and a PE ratio of -14,758.18. Circle Internet Group has a twelve month low of $64.00 and a twelve month high of $298.99.

Read Our Latest Research Report on CRCL

Blackstone (BX)

Blackstone Inc. is an alternative asset management firm specializing in real estate, private equity, hedge fund solutions, credit, secondary funds of funds, public debt and equity and multi-asset class strategies. The firm typically invests in early-stage companies. It also provide capital markets services.

NYSE BX traded down $1.85 during mid-day trading on Friday, reaching $162.21. 3,976,798 shares of the stock were exchanged, compared to its average volume of 3,887,856. Blackstone has a one year low of $115.66 and a one year high of $200.96. The stock has a 50 day simple moving average of $143.68 and a 200-day simple moving average of $150.98. The stock has a market cap of $118.36 billion, a P/E ratio of 48.86, a P/E/G ratio of 1.50 and a beta of 1.65. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.75 and a quick ratio of 0.75.

Read Our Latest Research Report on BX

BlackRock (BLK)

BlackRock, Inc. is a publicly owned investment manager. The firm primarily provides its services to institutional, intermediary, and individual investors including corporate, public, union, and industry pension plans, insurance companies, third-party mutual funds, endowments, public institutions, governments, foundations, charities, sovereign wealth funds, corporations, official institutions, and banks.

NYSE BLK traded down $1.42 during mid-day trading on Friday, reaching $1,102.63. 545,380 shares of the stock were exchanged, compared to its average volume of 693,726. BlackRock has a one year low of $773.74 and a one year high of $1,105.72. The company has a debt-to-equity ratio of 0.38, a current ratio of 4.34 and a quick ratio of 4.34. The stock has a market cap of $170.83 billion, a P/E ratio of 26.79, a P/E/G ratio of 2.24 and a beta of 1.41. The stock has a 50 day simple moving average of $996.68 and a 200-day simple moving average of $971.61.

Read Our Latest Research Report on BLK

Blueprint Medicines (BPMC)

Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of indolent SM, and other mast cell disorders.

BPMC traded down $0.03 during midday trading on Friday, hitting $129.30. The company had a trading volume of 3,570,356 shares, compared to its average volume of 1,382,134. Blueprint Medicines has a 52 week low of $73.04 and a 52 week high of $129.49. The company has a quick ratio of 2.75, a current ratio of 2.80 and a debt-to-equity ratio of 1.01. The company has a market capitalization of $8.35 billion, a price-to-earnings ratio of -52.35 and a beta of 0.89. The stock's 50 day moving average price is $117.02 and its 200 day moving average price is $101.75.

Read Our Latest Research Report on BPMC

Novo Nordisk A/S (NVO)

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.

Shares of NYSE:NVO traded down $2.08 during midday trading on Friday, hitting $68.93. 6,511,310 shares of the company's stock were exchanged, compared to its average volume of 7,316,084. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.74 and a quick ratio of 0.56. The stock has a 50 day moving average price of $70.35 and a 200-day moving average price of $75.08. The company has a market cap of $307.77 billion, a PE ratio of 20.39, a price-to-earnings-growth ratio of 1.38 and a beta of 0.64. Novo Nordisk A/S has a 12 month low of $57.00 and a 12 month high of $143.49.

Read Our Latest Research Report on NVO